Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

Alzheimer's disease (AD) is a neurodegenerative condition characterized by a gradual decline in cognitive functions. Currently, there are no effective treatments for AD, underscoring the importance of identifying individuals in the preclinical stages of mild cognitive impairment (MCI) to enable earl...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fernando García-Gutiérrez, Marta Marquié, Nathalia Muñoz, Montserrat Alegret, Amanda Cano, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Raquel Puerta, Adelina Orellana, Laura Montrreal, Vanesa Pytel, Mario Ricciardi, Carla Zaldua, Peru Gabirondo, Wolfram Hinzen, Núria Lleonart, Ainhoa García-Sánchez, Lluís Tárraga, Agustín Ruiz, Mercè Boada, Sergi Valero
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-09-01
Col·lecció:	Frontiers in Neuroscience
Matèries:	Alzheimer's disease mild cognitive impairment early diagnosis cerebrospinal fluid biomarkers machine learning
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1221401/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!